Mala Chakraborty

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial”.

Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial

Clinical Infectious Diseases(2021)10.1093/cid/ciab732

N/A

2.2DataRank · unranked

63 citations

Xin Tian, Mohamed Samour, Christopher S. King, Oksana A. Shlobin, Robert Reger +29 more

Augmentation of NK Cell Proliferation and Anti-tumor Immunity by Transgenic Expression of Receptors for EPO or TPO

Molecular Therapy(2020)10.1016/j.ymthe.2020.09.023

N/A

0DataRank · unranked

14 citations

David Allan, Mala Chakraborty, Robert Reger, Richard Childs, Chantiya Chanswangphuwana

Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.01.008

N/A

0DataRank · unranked

60 citations

Mala Chakraborty, Giacomo Waller, Michael J. Hochman, Akkapon Poolcharoen, Robert Reger +2 more

Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19

Science Advances(2023)10.1126/sciadv.ade8272

N/A

0DataRank · unranked

29 citations

Seth Warner, Marcos J. Ramos-Benítez, Lela Kardava, Xin Tian, Rui Miao +17 more